Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
US-2025002497-A1 · Jan 2, 2025 · US
This page is not indexed by search engines while we improve data quality.
Guy Julia patents
Guy Julia is listed as an inventor on 13 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Guy Julia |
| Total patents | 13 |
| First publication | Apr 2, 2015 |
| Latest publication | Jan 2, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation
US-12084452-B2 · Sep 10, 2024 · US
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
US-2023242535-A1 · Aug 3, 2023 · US
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation
US-10822343-B2 · Nov 3, 2020 · US
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (par4) inhibitors for treating platelet aggregation
US-2020123160-A1 · Apr 23, 2020 · US
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation
US-10428077-B2 · Oct 1, 2019 · US
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (par4) inhibitors for treating platelet aggregation
US-2018305376-A1 · Oct 25, 2018 · US
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation
US-10047103-B2 · Aug 14, 2018 · US
Imidazothiadiazole derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation
US-9862730-B2 · Jan 9, 2018 · US
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (par4) inhibitors for treating platelet aggregation
US-2017247395-A1 · Aug 31, 2017 · US
Recent patents
Latest publications not already listed above.
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation
US-9688695-B2 · Jun 27, 2017 · US
Imidazothiadiazole derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
US-2015133446-A1 · May 14, 2015 · US
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
US-2015094297-A1 · Apr 2, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Bristol Myers Squibb Co | 13 |
| Univ Montreal | 12 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P43/00 | 13 |
| A61P7/02 | 13 |
| A61K31/433 | 13 |
| A61K31/5377 | 13 |
| C07D513/04 | 13 |